StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.57−0.11 (-2.02%)

Close on Nov 18, 2026Market cap $147.82MP/E –Yield –

Inogen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Inogen's operating income for the twelve months ending Jun 30, 2026 was -$30.85M. For fiscal 2025 it was -$30.21M. The highest annual figure on record is $37.89M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$30.21M–
FY2024Dec 31, 2024-$42.52M–
FY2023Dec 31, 2023-$109.39M–
FY2022Dec 31, 2022-$85.24M-1022.5%
FY2021Dec 31, 2021$9.24M–
FY2020Dec 31, 2020-$12.03M-160.8%
FY2019Dec 31, 2019$19.79M-47.8%
FY2018Dec 31, 2018$37.89M+37.3%
FY2017Dec 31, 2017$27.59M+20.7%
FY2016Dec 31, 2016$22.86M+51.9%
FY2015Dec 31, 2015$15.05M+43.2%
FY2014Dec 31, 2014$10.51M+135.5%
FY2013Dec 31, 2013$4.46M+438.5%
FY2012Dec 31, 2012$829.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.10M–
Q1 FY2026Mar 31, 2026-$9.34M–
Q4 FY2025Dec 31, 2025-$9.31M–
Q3 FY2025Sep 30, 2025-$7.12M–
Q2 FY2025Jun 30, 2025-$6.13M–
Q1 FY2025Mar 31, 2025-$7.66M–
Q4 FY2024Dec 31, 2024-$11.39M–
Q3 FY2024Sep 30, 2024-$7.79M–
Q2 FY2024Jun 30, 2024-$7.06M–
Q1 FY2024Mar 31, 2024-$16.27M–
Q4 FY2023Dec 31, 2023-$28.98M–
Q3 FY2023Sep 30, 2023-$46.72M–
Q2 FY2023Jun 30, 2023-$11.77M–
Q1 FY2023Mar 31, 2023-$21.92M–
Q4 FY2022Dec 31, 2022-$58.49M–
Q3 FY2022Sep 30, 2022-$10.29M-261.5%
Q2 FY2022Jun 30, 2022-$2.88M-124.6%
Q1 FY2022Mar 31, 2022-$13.59M–
Q4 FY2021Dec 31, 2021-$6.67M–
Q3 FY2021Sep 30, 2021$6.37M–
Q2 FY2021Jun 30, 2021$11.67M–
Q1 FY2021Mar 31, 2021-$2.13M–
Q4 FY2020Dec 31, 2020-$5.52M–
Q3 FY2020Sep 30, 2020-$1.97M-124.3%
Q2 FY2020Jun 30, 2020-$2.35M-119.4%
Q1 FY2020Mar 31, 2020-$2.18M-144.9%
Q4 FY2019Dec 31, 2019-$5.32M-211.4%
Q3 FY2019Sep 30, 2019$8.11M-22.0%
Q2 FY2019Jun 30, 2019$12.15M-13.4%
Q1 FY2019Mar 31, 2019$4.86M-44.2%
Q4 FY2018Dec 31, 2018$4.78M-8.0%
Q3 FY2018Sep 30, 2018$10.40M+24.8%
Q2 FY2018Jun 30, 2018$14.02M+65.0%
Q1 FY2018Mar 31, 2018$8.70M+56.2%
Q4 FY2017Dec 31, 2017$5.19M-15.9%
Q3 FY2017Sep 30, 2017$8.33M+54.4%
Q2 FY2017Jun 30, 2017$8.50M–
Q1 FY2017Mar 31, 2017$5.57M–
Q4 FY2016Dec 31, 2016$6.17M–
Q3 FY2016Sep 30, 2016$5.40M–

More Inogen figures

See a number that looks wrong?